NEWMarkets

Protagonist Therapeutics CMO Sells $1.57 Million in Company Shares

Published on 3/27/2026

#ProtagonistTherapeutics#insidertrading#CMOsale
Protagonist Therapeutics CMO Sells $1.57 Million in Company Shares

AI Summary

Protagonist Therapeutics' Chief Medical Officer sold shares totaling $1.57 million. This transaction comes as the company continues its development in therapeutic treatments. The sale may raise questions about insider sentiment towards the company's future performance. Monitoring such insider trading activities can provide insights into potential market reactions and investor confidence.

Source: Read original article (opens in new tab)

Related News

Dow Falls 800 Points Entering Correction; S&P 500 Faces Longest Losing Streak
Markets

Dow Falls 800 Points Entering Correction; S&P 500 Faces Longest Losing Streak

Mar 28

Inspired Entertainment CEO Pierce Brooks H Acquires $136K in Company Stock
Markets

Inspired Entertainment CEO Pierce Brooks H Acquires $136K in Company Stock

Mar 27

U.S. Tech Sector Experiences Pullback Similar to Dotcom Era Trends
Markets

U.S. Tech Sector Experiences Pullback Similar to Dotcom Era Trends

Mar 27

Protagonist Therapeutics Director Selick Sells $2.52 Million in Shares
Markets

Protagonist Therapeutics Director Selick Sells $2.52 Million in Shares

Mar 27